SEARCH

SEARCH BY CITATION

References

  • Barosi, G., Ambrosetti, A., Finelli, C., Grossi, A., Leoni, P., Liberato, N.L., Petti, M.C., Pogliani, E., Ricetti, M., Rupoli, S., Visani, G., Tura, S. (1999) The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia. British Journal of Haematology, 104, 730737.
  • Bench, A.J., Nacheva, E.P., Champion, K.M., Green, A.R. (1998) Molecular genetics and cytogenetics of myeloproliferative disorders. Bailliere's Clinical Haematology, 11, 819848.
  • Berk, P.D., Wasserman, L.R., Fruchtman, S.M., Goldberg, J.D. (1995) Treatment of polycythaemia vera: a summary of clinical trials conducted by the Polycythaemia Vera Study Group. In: Polycythaemia Vera and the Myeloproliferative Disorders (ed. by L.R.Wasserman, P.D.Berk & N.I.Berlin), pp. 166194. W.B. Saunders, Philadelphia.
  • Besa, E.C., Nowell, P.C., Geller, N.L., Gardner, F.H. (1982) Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: the value of chromosomal studies in predicting response and survival. Cancer, 49, 308313.
  • Byrd, J.C., Lawrence, D., Arthur, D.C., Pettenati, M.J., Tantravahi, R., Qumsiyeh, M., Stamberg, J., Davey, F.R., Schiffer, C.A., Bloomfield, C.D. (1998) Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461. Clinical Cancer Research, 4, 12351241.
  • Campbell, L.J. & Garson, O.M. (1994) The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders. Leukemia, 8, 6771.
  • Cervantes, F., Pereira, A., Esteve, J., Rafel, M., Cobo, F., Rozman, C., Montserrat, E. (1997) Identification of ‘short-lived’ and ‘long-lived’ patients at presentation of idiopathic myelofibrosis. British Journal of Haematology, 97, 635640.
  • Cervantes, F., Barosi, G., Demory, J.L., Reilly, J., Guarnone, R., Dupriez, B., Pereira, A., Montserrat, E. (1998) Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups. British Journal of Haematology, 102, 684690.
  • Daley, G.Q., Van Etten, R.A., Baltimore, D. (1990) Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science, 247, 824830.
  • Demory, J.L., Dupriez, B., Fenaux, P., Lai, J.L., Beuscart, R., Jouet, J.P., Derminatti, M., Bauters, F. (1988) Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood, 72, 855859.
  • De The, H., Chomienne, C., Lanotte, M., Degos, L., Dejean, A. (1990) The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature, 347, 558561.
  • Dewald, G.W. & Wright, P.I. (1995) Chromosome abnormalities in the myeloproliferative disorders. Seminars in Oncology, 22, 341354.
  • Dewald, G.W., Broderick, D.J., Tom, W.W., Hagstrom, J.E., Pierre, R.V. (1985) The efficacy of direct, 24-hour culture, and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic hematologic disorders. Cancer Genetics and Cytogenetics, 18, 110.
  • Dickstein, J.I. & Vardiman, J.W. (1995) Hematopathologic findings in the myeloproliferative disorders. Seminars in Oncology, 22, 355373.
  • Diez-Martin, J.L., Graham, D.L., Petitt, R.M., Dewald, G.W. (1991) Chromosome studies in 104 patients with polycythaemia vera. Mayo Clinic Proceedings, 66, 287299.
  • Druker, B.J. & Lydon, N.B. (2000) Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. Journal of Clinical Investigation, 105, 37.
  • Dupriez, B., Morel, P., Demory, J.L., Lai, J.L., Simon, M., Plantier, I., Bauters, F. (1996) Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood, 88, 10131018.
  • Gilbert, H.S. (1998) Long term treatment of myeloproliferative disease with interferon-alpha-2b: feasibility and efficacy. Cancer, 83, 12051213.
  • Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G., Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 20792088.
  • Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., Goldstone, A. (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood, 92, 23222333.
  • Guardiola, P., Anderson, J.E., Bandini, G., Cervantes, F., Runde, V., Arcese, W., Bacigalupo, A., Przepiorka, D., O'Donnell, M.R., Polchi, P., Buzyn, A., Sutton, L., Cazals-Hatem, D., Sale, G., De Witte, T., Deeg, H.J., Gluckman, E. (1999) Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study. Blood, 93, 28312838.
  • Huang, M.E., Ye, Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhoa, L., Gu, L.J., Wang, Z.Y. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567572.
  • Jacobson, R.J., Salo, A., Fialkow, P.J. (1978) Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood, 51, 189194.
  • Johnson, D.D., Dewald, G.W., Pierre, R.V., Letendre, L., Silverstein, M.N. (1985) Deletions of chromosome 13 in malignant hematologic disorders. Cancer Genetics and Cytogenetics, 18, 235241.
  • Juliusson, G. & Merup, M. (1998) Cytogenetics in chronic lymphocytic leukemia. Seminars in Oncology, 25, 1926.
  • Kvasnicka, H.M., Thiele, J., Werden, C., Zankovich, R., Diehl, V., Fischer, R. (1997) Prognostic factors in idiopathic (primary) osteomyelofibrosis. Cancer, 80, 708719.
  • Larson, R.A., Kondo, K., Vardiman, J.W., Butler, A.E., Golomb, H.M., Rowley, J.D. (1984) Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. American Journal of Medicine, 76, 827841.
  • La Starza, R., Wlodarska, I., Aventin, A., Falzetti, D., Crescenzi, B., Martelli, M.F., Van den Berghe, H., Mecucci, C. (1998) Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies. Blood, 91, 231237.
  • Lowenberg, B., Hagemeijer, A., Swart, K. (1982) Karyotypically distinct subpopulations in acute leukemia with specific growth requirements. Blood, 59, 641645.
  • Manoharan, A. (1991) Management of myelofibrosis with intermittent hydroxyurea. British Journal of Haematology, 77, 252254.
  • Martyre, M.C., Romquin, N., Le Bousse-Kerdiles, M.C., Chevillard, S., Benyahia, B., Dupriez, B., Demory, J.L., Bauters, F. (1994) Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. British Journal of Haematology, 88, 916.
  • Mesa, R.A., Hanson, C.A., Rajkumar, S.V., Schroeder, G., Tefferi, A. (2000) Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood, 96, 33743380.
  • Najean, Y. & Rain, J.D. (1997) The very long-term evolution of polycythemia vera: an analysis of 318 patients initially treated by phlebotomy or 32P between 1969 and 1981. Seminars in Hematology, 34, 616.
  • Nowell, P.C. & Hungerford, D.A. (1960) Chromosome studies on normal and leukemic human leukocytes. Journal of the National Cancer Institute, 25, 85109.
  • Pastore, C., Nomdedeu, J., Volpe, G., Guerrasio, A., Cambrin, G.R., Parvis, G., Pautasso, M., Daglio, C., Mazza, U., Saglio, G., Gaidano, G. (1995) Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders. Genes, Chromosomes and Cancer, 14, 106111.
  • Perkins, D., Brennan, S., Carstairs, K., Bailey, D., Pantalony, D., Poon, A., Fernandes, B., Dube, I. (1997) Regional cancer cytogenetics: a report on 1,143 diagnostic cases. Cancer Genetics and Cytogenetics, 96, 6480.
  • Rege-Cambrin, G., Mecucci, C., Tricot, G., Michaux, J.L., Louwagie, A., Van Hove, W., Francart, H., Van den Berghe, H. (1987) A chromosomal profile of polycythaemia vera. Cancer Genetics and Cytogenetics, 25, 233245.
  • Reilly, J.T. (1994) Pathogenesis of idiopathic myelofibrosis: present status and future directions. British Journal of Haematology, 88, 18.
  • Reilly, J.T., Snowden, J.A., Spearing, R.L., Fitzgerald, P.M., Jones, N., Watmore, A., Potter, A. (1997) Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases. British Journal of Haematology, 98, 96102.
  • Schoch, C., Haase, D., Fonatsch, C., Haferlach, T., Loffler, H., Schlegelberger, B., Hossfeld, D.K., Becher, R., Sauerland, M.C., Heinecke, A., Wormann, B., Buchner, T., Hidemann, W. (1997) The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group. British Journal of Haematology, 99, 605611.
  • Sole, F., Espinet, B., Sanz, G.F., Cervera, J., Calasanz, M.J., Luno, E., Prieto, F., Granada, I., Hernandez, J.M., Cigudosa, J.C., Diez, J.L., Bureo, E., Marques, M.L., Arranz, E., Rios, R., Martinez Climent, J.A., Vallespi, T., Florensa, L., Woessner, S. (2000) Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica Hematologica. British Journal of Haematology, 108, 346356.
  • Streubel, B., Sauerland, C., Heil, G., Freund, M., Bartels, H., Lengfelder, E., Wandt, H., Ludwig, W.D., Nowotny, H., Balfus, M., Grothaus-Pinke, B., Buchner, T., Fonatsch, C. (1998) Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12. British Journal of Haematology, 100, 521533.
  • Swolin, B., Weinfeld, A., Westin, J. (1988) A prospective long-term cytogenetic study in polycythaemia vera in relation to treatment and clinical course. Blood, 72, 386395.
  • Tamura, S., Kanamaru, A., Takemoto, Y., Kakishita, E., Nagai, K. (1993) Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow. British Journal of Haematology, 84, 219226.
  • Tanaka, K., Arif, M., Eguchi, M., Guo, S.X., Hayashi, Y., Asaoku, H., Kyo, T., Dohy, H., Kamada, N. (1999) Frequent allelic loss of the RB, D13S319 and D13S25 locus in myeloid malignancies with deletion/translocation at 13q14 of chromosome 13, but not in lymphoid malignancies. Leukemia, 13, 13671373.
  • Tefferi, A. (2000) Myelofibrosis with myeloid metaplasia. New England Journal of Medicine, 342, 12551265.
  • Tefferi, A., Mesa, R.A., Nagorney, D.M., Schroeder, G., Silverstein, M.N. (2000) Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood, 95, 22262233.
  • Tefferi, A., Fonseca, R., Pereira, D.L., Hoagland, H.C. (2001) A long-term retrospective study of young women with essential thrombocythemia. Mayo Clinic Proceedings, 76, 2228.
  • United Kingdom Cancer Cytogenetics Group (UKCCG) (1992) Translocations involving 12p in acute myeloid leukemia: association with prior myelodysplasia and exposure to mutagenic agents. Genes, Chromosomes and Cancer, 5, 252254.
  • Wada, M., Okamura, T., Okada, M., Teramura, M., Masuda, M., Motoji, T., Mizoguchi, H. (1999) Frequent chromosome arm 13q deletion in aggressive non-Hodgkin's lymphoma. Leukemia, 13, 792798.
  • Wang, J.C., Lang, H.D., Lichter, S., Weinstein, M., Benn, P. (1992) Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia. British Journal of Haematology, 80, 184188.
  • Werner, M., Nolte, M., Kaloutsi, V., Buhr, T., Kausche, F., Georgii, A. (1995) Karyotype findings and molecular analysis of the bcr gene rearrangement supplementing the histologic classification of chronic myeloproliferative disorders. Laboratory Investigation, 72, 405410.
  • Zojer, N., Konigsberg, R., Ackermann, J., Fritz, E., Dallinger, S., Kromer, E., Kaufmann, H., Riedl, L., Gisslinger, H., Schreiber, S., Heinz, R., Ludwig, H., Huber, H., Drach, J. (2000) Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Multi Center Investigation of Bone Marrow Transplantation for Sickle Cell Disease. Blood, 95, 19251930.